PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21438831-2	2011	We previously described the benefit of the THP-COP regimen comprising cyclophosphamide, THP, vincristine, and prednisolone for elderly patients with diffuse large B-cell lymphoma (DLBCL).	Cyclophosphamide	70-86	caspase recruitment domain family member 16	Homo sapiens	47-50	
17668812-9	2007	The patient was treated with R-COP regiment (six cycles rituximab + COP- cyclophosphamid, vincristin, prednisolon).	Cyclophosphamide	73-88	caspase recruitment domain family member 16	Homo sapiens	68-71	
18208780-8	2008	Chemotherapy using cyclophosphamide, vincristine and dexamethasone (COP modified) led to a dramatic response of the tumor and a complete resolution of compressive symptoms.	Cyclophosphamide	19-35	caspase recruitment domain family member 16	Homo sapiens	68-71	
14653077-5	2003	The CR rate and 5-year survival rate of patients who were treated by the scheme of doxorubicin, cyclophosphamide, vincristine and prednisone (CHOP) were higher than those treated by the scheme of cyclophosphamide, vincristine, prednisone and etoposide (COP + VP16) (P < 0.05).	Cyclophosphamide	96-112	caspase recruitment domain family member 16	Homo sapiens	253-256	
507741-1	1979	A case of localized lymphomatous polyposis of the rectum successfully treated with a combination of cyclophosphamide, vincristine and prednisone (COP regimen) is reported and the literature is briefly reviewed.	Cyclophosphamide	100-116	caspase recruitment domain family member 16	Homo sapiens	146-149	
1433946-7	1992	Treatment with F-COP (epirubicine, cyclophosphamide, vincristine, prednisolone) therapy, resulted in a dramatic improvement of her condition.	Cyclophosphamide	35-51	caspase recruitment domain family member 16	Homo sapiens	17-20	
27463490-4	1991	Chlorambucil (chl) given intermittently was compared with the combination COP in CLL 1: no differences in survival or response were observed although the response rate (CR + PR) of COP rose from 53% to 73% when the dose of cyclophosphamide was doubled; CR + PR with chl was 62%.	Cyclophosphamide	223-239	caspase recruitment domain family member 16	Homo sapiens	181-184	
8167175-4	1994	Three of these four patients had been treated with combined modality therapy followed by maintenance COP chemotherapy, resulting in high cumulative doses of cyclophosphamide (range: 12-43 g).	Cyclophosphamide	157-173	caspase recruitment domain family member 16	Homo sapiens	101-104	
6396563-2	1984	Chemotherapy with cyclophosphamide, vincristine and prednisone (COP) yielded partial response, but the addition of adriamycin (CHOP) a complete remission.	Cyclophosphamide	18-34	caspase recruitment domain family member 16	Homo sapiens	64-67	
28666424-8	2017	Significant improvement was noticed after three cycles of chemotherapy of THP-COP (pirarubicin, cyclophosphamide, vincristine, and prednisolone).	Cyclophosphamide	96-112	caspase recruitment domain family member 16	Homo sapiens	78-81	
33864237-4	2021	THP-COP (pirarubicin, cyclophosphamide, vincristine, and prednisone) is sometimes used for elderly patients with non-Hodgkin"s lymphoma in Japan.	Cyclophosphamide	22-38	caspase recruitment domain family member 16	Homo sapiens	4-7	
26809312-3	2015	The Japanese man was diagnosed with diffuse large B-cell lymphoma, and underwent chemotherapy treatment with THP-COP (cyclophosphamide, pirarubicin, vincristine, and prednisolone).	Cyclophosphamide	118-134	caspase recruitment domain family member 16	Homo sapiens	113-116